ELLEN FLANNERY , EDITOR

For our cover story , Dr Grace Terrell , Chief Medical Officer at IKS Health , discusses the transformative role of technology in healthcare reform . As a leader in healthcare innovation , Dr Terrell shares insights on leveraging HealthTech to improve patient outcomes , address disparities and support value-based payment models , drawing from her extensive experience in clinical practice and executive leadership .

“ Value-based care is different from traditional models in both how care is delivered and how it is paid . Technology needs are quite different between the two models of care . Instead of supporting transactional medicine , technology platforms for VBC need to provide longitudinal patient insights , support analysis at population cohort level and enable measurement of cost and quality outcomes ,” said Dr Terrell .

Read the full interview on page 48 . entire pharmaceutical R & D system to realise AI ’ s full potential and deliver groundbreaking new medicines .

With the election of a new government in the UK , this month ’ s Editor ’ s Question delves into the HealthTech industry and a Labour government on page 25 . To glean valuable insights from experts , I ask : What do UK HealthTech experts want from a Labour government ?

On page 29 , we breathe in yet another trend in the vape industry with the rise of ‘ herbal vape ’ options . With many question marks raised over the rise of illegal vapes and their safety , a new study by experts at online vape retailer , Vape and Go , has examined the rise of herbal vapes in the UK and whether this may offer a healthier solution to traditional nicotine vapes .

In this month ’ s Under the Microscope , at this year ’ s HLTH Europe event in Amsterdam , I sat down with Peter Grinbergs , Chief Medical Officer and Co-founder of EQL . Peter discusses how digital healthcare is transforming physiotherapy , the importance of timely assessments and the role of technology in improving patient outcomes on page 60 .

We also have a range of ‘ Intelligent ’ pages , which feature the latest in Artificial Intelligence , cloud , wearable technology , robotics , security and Virtual Reality .

I hope you enjoy this issue and if you want to contribute to any future editions , please contact me .

Ellen Flannery , Editor

Could billions of dollars in AI funding lead to the same number of new drugs ? On page 39 , Ashu Singhal and Sajith Wickramasekara , Co-founders of Benchling , argue that massive investments in AI-driven BioTech must be matched by overhauls in the

TO OUR MONTHLY MAGAZINE

www . intelligenthealth . tech 3